Group name
SBx patients
Groups remarks
standard untargeted biopsy
T2a
15 (12.3)
T2b
2 (1.7)
T2c
47 (40.3)
T3a
42 (36.2)
>T3b
11 (9.5)
remark
Pathological stage,n (%)